National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 311428

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

VAERS ID: 311428
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-01-03
Onset:2008-02-09
Submitted:2008-05-02
Entered:2008-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Surgery, Ultrasound abdomen abnormal, Intestinal resection, Abdominal X-ray

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal X-ray 09Feb2008 see text unit; Ultrasound abdomen 09Feb2008 see text unit.
CDC 'Split Type': B0509214A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 4-month-old female subject who was vaccinated with ROTARIX, GlaxoSmithKline. Previous vaccination included INFANRIX HEXA, GlaxoSmithKline; intramuscular, 1st dose left low inferior member given on 4 December 2007; PREVENAR; Wyeth Labs; intramuscular, 1st dose; right low inferior member given on 4 December 2007. On 3 January 2008 the subject received 1st dose of ROTARIX (oral). On 08 February 2008 the subject received the second dose of INFANRIX HEXA and PREVENAR. On 9 February 2008, 37 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised and the physician considered the event was life threatening and clinically significant (or requiring intervention). Relevant test results included abdominal x-ray which showed fluid levels and dilated bowel loops and the abdominal ultrasound showed a visible intussusception or soft tissue mass. The subject was treated with surgery on 10 February 2008. Intussusception was demonstrated at surgery. The subject required bowel resection. It was reported that complications occurred at radiological procedure but no details were provided. At the time of reporting the outcome of the event was unspecified. The physician considered the event was almost certainly related to vaccination with ROTARIX. In the follow up received on 25 April 2008 it was mentioned that the physician did not report and signs nor symptoms. Besides it was clarified that the complication at radiological procedure was an intestinal track perforation. On 15 April 2008 the subject was fully recovered.


Changed on 1/5/2010

VAERS ID: 311428 Before After
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-01-03
Onset:2008-02-09
Submitted:2008-05-02
Entered:2008-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (UNKNOWN) / GLAXOSMITHKLINE BIOLOGICALS (UNKNOWN) - / - - / -
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Surgery, Ultrasound abdomen abnormal, Intestinal resection, Abdominal X-ray

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0 (blank)     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal X-ray 09Feb2008 see text unit; Ultrasound abdomen 09Feb2008 see text unit.
CDC 'Split Type': B0509214A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 4-month-old female subject who was vaccinated with ROTARIX, GlaxoSmithKline. Previous vaccination included INFANRIX HEXA, GlaxoSmithKline; intramuscular, 1st dose left low inferior member given on 4 December 2007; PREVENAR; Wyeth Labs; intramuscular, 1st dose; right low inferior member given on 4 December 2007. On 3 January 2008 the subject received 1st dose of ROTARIX (oral). On 08 February 2008 the subject received the second dose of INFANRIX HEXA and PREVENAR. On 9 February 2008, 37 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised and the physician considered the event was life threatening and clinically significant (or requiring intervention). Relevant test results included abdominal x-ray which showed fluid levels and dilated bowel loops and the abdominal ultrasound showed a visible intussusception or soft tissue mass. The subject was treated with surgery on 10 February 2008. Intussusception was demonstrated at surgery. The subject required bowel resection. It was reported that complications occurred at radiological procedure but no details were provided. At the time of reporting the outcome of the event was unspecified. The physician considered the event was almost certainly related to vaccination with ROTARIX. In the follow up received on 25 April 2008 it was mentioned that the physician did not report and signs nor symptoms. Besides it was clarified that the complication at radiological procedure was an intestinal track perforation. On 15 April 2008 the subject was fully recovered.


Changed on 8/31/2010

VAERS ID: 311428 Before After
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-01-03
Onset:2008-02-09
Submitted:2008-05-02
Entered:2008-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (UNKNOWN) DTAP+IPV+HEPB+HIB (NO BRAND NAME) / GLAXOSMITHKLINE BIOLOGICALS (UNKNOWN) - / - - / -
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Surgery, Ultrasound abdomen abnormal, Intestinal resection, Abdominal X-ray

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal X-ray 09Feb2008 see text unit; Ultrasound abdomen 09Feb2008 see text unit.
CDC 'Split Type': B0509214A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 4-month-old female subject who was vaccinated with ROTARIX, GlaxoSmithKline. Previous vaccination included INFANRIX HEXA, GlaxoSmithKline; intramuscular, 1st dose left low inferior member given on 4 December 2007; PREVENAR; Wyeth Labs; intramuscular, 1st dose; right low inferior member given on 4 December 2007. On 3 January 2008 the subject received 1st dose of ROTARIX (oral). On 08 February 2008 the subject received the second dose of INFANRIX HEXA and PREVENAR. On 9 February 2008, 37 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised and the physician considered the event was life threatening and clinically significant (or requiring intervention). Relevant test results included abdominal x-ray which showed fluid levels and dilated bowel loops and the abdominal ultrasound showed a visible intussusception or soft tissue mass. The subject was treated with surgery on 10 February 2008. Intussusception was demonstrated at surgery. The subject required bowel resection. It was reported that complications occurred at radiological procedure but no details were provided. At the time of reporting the outcome of the event was unspecified. The physician considered the event was almost certainly related to vaccination with ROTARIX. In the follow up received on 25 April 2008 it was mentioned that the physician did not report and signs nor symptoms. Besides it was clarified that the complication at radiological procedure was an intestinal track perforation. On 15 April 2008 the subject was fully recovered.


Changed on 11/3/2010

VAERS ID: 311428 Before After
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-01-03
Onset:2008-02-09
Submitted:2008-05-02
Entered:2008-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (NO BRAND NAME) DTAP+IPV+HEPB+HIB (FOREIGN) / GLAXOSMITHKLINE BIOLOGICALS (UNKNOWN) - / - - / -
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Surgery, Ultrasound abdomen abnormal, Intestinal resection, Abdominal X-ray

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal X-ray 09Feb2008 see text unit; Ultrasound abdomen 09Feb2008 see text unit.
CDC 'Split Type': B0509214A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 4-month-old female subject who was vaccinated with ROTARIX, GlaxoSmithKline. Previous vaccination included INFANRIX HEXA, GlaxoSmithKline; intramuscular, 1st dose left low inferior member given on 4 December 2007; PREVENAR; Wyeth Labs; intramuscular, 1st dose; right low inferior member given on 4 December 2007. On 3 January 2008 the subject received 1st dose of ROTARIX (oral). On 08 February 2008 the subject received the second dose of INFANRIX HEXA and PREVENAR. On 9 February 2008, 37 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised and the physician considered the event was life threatening and clinically significant (or requiring intervention). Relevant test results included abdominal x-ray which showed fluid levels and dilated bowel loops and the abdominal ultrasound showed a visible intussusception or soft tissue mass. The subject was treated with surgery on 10 February 2008. Intussusception was demonstrated at surgery. The subject required bowel resection. It was reported that complications occurred at radiological procedure but no details were provided. At the time of reporting the outcome of the event was unspecified. The physician considered the event was almost certainly related to vaccination with ROTARIX. In the follow up received on 25 April 2008 it was mentioned that the physician did not report and signs nor symptoms. Besides it was clarified that the complication at radiological procedure was an intestinal track perforation. On 15 April 2008 the subject was fully recovered.


Changed on 1/4/2011

VAERS ID: 311428 Before After
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-01-03
Onset:2008-02-09
Submitted:2008-05-02
Entered:2008-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (FOREIGN) / GLAXOSMITHKLINE BIOLOGICALS (UNKNOWN) GLAXOSMITHKLINE BIOLOGICALS - / - - / -
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Surgery, Ultrasound abdomen abnormal, Intestinal resection, Abdominal X-ray

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal X-ray 09Feb2008 see text unit; Ultrasound abdomen 09Feb2008 see text unit.
CDC 'Split Type': B0509214A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 4-month-old female subject who was vaccinated with ROTARIX, GlaxoSmithKline. Previous vaccination included INFANRIX HEXA, GlaxoSmithKline; intramuscular, 1st dose left low inferior member given on 4 December 2007; PREVENAR; Wyeth Labs; intramuscular, 1st dose; right low inferior member given on 4 December 2007. On 3 January 2008 the subject received 1st dose of ROTARIX (oral). On 08 February 2008 the subject received the second dose of INFANRIX HEXA and PREVENAR. On 9 February 2008, 37 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised and the physician considered the event was life threatening and clinically significant (or requiring intervention). Relevant test results included abdominal x-ray which showed fluid levels and dilated bowel loops and the abdominal ultrasound showed a visible intussusception or soft tissue mass. The subject was treated with surgery on 10 February 2008. Intussusception was demonstrated at surgery. The subject required bowel resection. It was reported that complications occurred at radiological procedure but no details were provided. At the time of reporting the outcome of the event was unspecified. The physician considered the event was almost certainly related to vaccination with ROTARIX. In the follow up received on 25 April 2008 it was mentioned that the physician did not report and signs nor symptoms. Besides it was clarified that the complication at radiological procedure was an intestinal track perforation. On 15 April 2008 the subject was fully recovered.


Changed on 5/13/2013

VAERS ID: 311428 Before After
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-01-03
Onset:2008-02-09
Submitted:2008-05-02
Entered:2008-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (FOREIGN) / GLAXOSMITHKLINE BIOLOGICALS - / - - / -
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - - / PO
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Surgery, Ultrasound abdomen abnormal, Intestinal resection, Abdominal X-ray

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal X-ray 09Feb2008 see text unit; Ultrasound abdomen 09Feb2008 see text unit.
CDC 'Split Type': B0509214A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 4-month-old female subject who was vaccinated with ROTARIX, GlaxoSmithKline. Previous vaccination included INFANRIX HEXA, GlaxoSmithKline; intramuscular, 1st dose left low inferior member given on 4 December 2007; PREVENAR; Wyeth Labs; intramuscular, 1st dose; right low inferior member given on 4 December 2007. On 3 January 2008 the subject received 1st dose of ROTARIX (oral). On 08 February 2008 the subject received the second dose of INFANRIX HEXA and PREVENAR. On 9 February 2008, 37 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised and the physician considered the event was life threatening and clinically significant (or requiring intervention). Relevant test results included abdominal x-ray which showed fluid levels and dilated bowel loops and the abdominal ultrasound showed a visible intussusception or soft tissue mass. The subject was treated with surgery on 10 February 2008. Intussusception was demonstrated at surgery. The subject required bowel resection. It was reported that complications occurred at radiological procedure but no details were provided. At the time of reporting the outcome of the event was unspecified. The physician considered the event was almost certainly related to vaccination with ROTARIX. In the follow up received on 25 April 2008 it was mentioned that the physician did not report and signs nor symptoms. Besides it was clarified that the complication at radiological procedure was an intestinal track perforation. On 15 April 2008 the subject was fully recovered.


Changed on 5/14/2017

VAERS ID: 311428 Before After
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-01-03
Onset:2008-02-09
Submitted:2008-05-02
Entered:2008-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (FOREIGN) DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS - / - - / -
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Surgery, Ultrasound abdomen abnormal, Intestinal resection, Abdominal X-ray

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal X-ray 09Feb2008 see text unit; Ultrasound abdomen 09Feb2008 see text unit.
CDC 'Split Type': B0509214A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 4-month-old female subject who was vaccinated with ROTARIX, GlaxoSmithKline. Previous vaccination included INFANRIX HEXA, GlaxoSmithKline; intramuscular, 1st dose left low inferior member given on 4 December 2007; PREVENAR; Wyeth Labs; intramuscular, 1st dose; right low inferior member given on 4 December 2007. On 3 January 2008 the subject received 1st dose of ROTARIX (oral). On 08 February 2008 the subject received the second dose of INFANRIX HEXA and PREVENAR. On 9 February 2008, 37 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised and the physician considered the event was life threatening and clinically significant (or requiring intervention). Relevant test results included abdominal x-ray which showed fluid levels and dilated bowel loops and the abdominal ultrasound showed a visible intussusception or soft tissue mass. The subject was treated with surgery on 10 February 2008. Intussusception was demonstrated at surgery. The subject required bowel resection. It was reported that complications occurred at radiological procedure but no details were provided. At the time of reporting the outcome of the event was unspecified. The physician considered the event was almost certainly related to vaccination with ROTARIX. In the follow up received on 25 April 2008 it was mentioned that the physician did not report and signs nor symptoms. Besides it was clarified that the complication at radiological procedure was an intestinal track perforation. On 15 April 2008 the subject was fully recovered.


Changed on 9/14/2017

VAERS ID: 311428 Before After
VAERS Form:(blank) 1
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-01-03
Onset:2008-02-09
Submitted:2008-05-02
Entered:2008-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS - / - UNK - / -
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - UNK - MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Surgery, Ultrasound abdomen abnormal, Intestinal resection, Abdominal X-ray

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal X-ray 09Feb2008 see text unit; Ultrasound abdomen 09Feb2008 see text unit.
CDC 'Split Type': B0509214A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 4-month-old female subject who was vaccinated with ROTARIX, GlaxoSmithKline. Previous vaccination included INFANRIX HEXA, GlaxoSmithKline; intramuscular, 1st dose left low inferior member given on 4 December 2007; PREVENAR; Wyeth Labs; intramuscular, 1st dose; right low inferior member given on 4 December 2007. On 3 January 2008 the subject received 1st dose of ROTARIX (oral). On 08 February 2008 the subject received the second dose of INFANRIX HEXA and PREVENAR. On 9 February 2008, 37 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised and the physician considered the event was life threatening and clinically significant (or requiring intervention). Relevant test results included abdominal x-ray which showed fluid levels and dilated bowel loops and the abdominal ultrasound showed a visible intussusception or soft tissue mass. The subject was treated with surgery on 10 February 2008. Intussusception was demonstrated at surgery. The subject required bowel resection. It was reported that complications occurred at radiological procedure but no details were provided. At the time of reporting the outcome of the event was unspecified. The physician considered the event was almost certainly related to vaccination with ROTARIX. In the follow up received on 25 April 2008 it was mentioned that the physician did not report and signs nor symptoms. Besides it was clarified that the complication at radiological procedure was an intestinal track perforation. On 15 April 2008 the subject was fully recovered.


Changed on 2/14/2018

VAERS ID: 311428 Before After
VAERS Form:1
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-01-03
Onset:2008-02-09
Submitted:2008-05-02
Entered:2008-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Surgery, Ultrasound abdomen abnormal, Intestinal resection, Abdominal X-ray

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal X-ray 09Feb2008 see text unit; Ultrasound abdomen 09Feb2008 see text unit.
CDC 'Split Type': B0509214A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 4-month-old female subject who was vaccinated with ROTARIX, GlaxoSmithKline. Previous vaccination included INFANRIX HEXA, GlaxoSmithKline; intramuscular, 1st dose left low inferior member given on 4 December 2007; PREVENAR; Wyeth Labs; intramuscular, 1st dose; right low inferior member given on 4 December 2007. On 3 January 2008 the subject received 1st dose of ROTARIX (oral). On 08 February 2008 the subject received the second dose of INFANRIX HEXA and PREVENAR. On 9 February 2008, 37 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised and the physician considered the event was life threatening and clinically significant (or requiring intervention). Relevant test results included abdominal x-ray which showed fluid levels and dilated bowel loops and the abdominal ultrasound showed a visible intussusception or soft tissue mass. The subject was treated with surgery on 10 February 2008. Intussusception was demonstrated at surgery. The subject required bowel resection. It was reported that complications occurred at radiological procedure but no details were provided. At the time of reporting the outcome of the event was unspecified. The physician considered the event was almost certainly related to vaccination with ROTARIX. In the follow up received on 25 April 2008 it was mentioned that the physician did not report and signs nor symptoms. Besides it was clarified that the complication at radiological procedure was an intestinal track perforation. On 15 April 2008 the subject was fully recovered.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=311428&WAYBACKHISTORY=ON


Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166